Tumor imaging by means of proteolytic activation of cell-penetrating peptides
about
Comparative assessment of substrates and activity based probes as tools for non-invasive optical imaging of cysteine protease activityMechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivoSmart nanosystems: Bio-inspired technologies that interact with the host environmentDendrimer advances for the central nervous system delivery of therapeuticsAdvances in molecular imaging: targeted optical contrast agents for cancer diagnosticsCancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Fluorescent imaging of cancerous tissues for targeted surgery.Enzyme-responsive nanomaterials for controlled drug deliveryFluorescent peptide biosensor for probing the relative abundance of cyclin-dependent kinases in living cellsTumor Detection at 3 Tesla with an Activatable Cell Penetrating Peptide Dendrimer (ACPPD-Gd), a T1 Magnetic Resonance (MR) Molecular Imaging AgentSelective Vaporization of Superheated Nanodroplets for Rapid, Sensitive, Acoustic Biosensing.Molecular imaging for cancer diagnosis and surgery.Synthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical ProbesAdvances in fluorescent-image guided surgeryCPP-Assisted Intracellular Drug Delivery, What Is Next?Non-invasive imaging of cysteine cathepsin activity in solid tumors using a 64Cu-labeled activity-based probeIdentification, characterization and application of a G-quadruplex structured DNA aptamer against cancer biomarker protein anterior gradient homolog 2Near-infrared optical proteolytic beacons for in vivo imaging of matrix metalloproteinase activityMatrix metalloproteinases: regulators of the tumor microenvironmentImaging in pancreatic disease.Protease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging.Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.Mutually-Reactive, Fluorogenic Hydrocyanine/Quinone Reporter Pairs for In-Solution Biosensing via Nanodroplet Association.Photoacoustic lifetime contrast between methylene blue monomers and self-quenched dimers as a model for dual-labeled activatable probes.Molecular photoacoustic imaging of follicular thyroid carcinoma.New strategies for fluorescent probe design in medical diagnostic imaging.A window on disease pathogenesis and potential therapeutic strategies: molecular imaging for arthritis.Preclinical molecular imaging of tumor angiogenesis.Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer.H-type dimer formation of fluorophores: a mechanism for activatable, in vivo optical molecular imagingReal-time in vivo molecular detection of primary tumors and metastases with ratiometric activatable cell-penetrating peptides.Design of Protease Activated Optical Contrast Agents That Exploit a Latent Lysosomotropic Effect for Use in Fluorescence-Guided Surgery.Fluorescent Image-Guided Surgery with an Anti-Prostate Stem Cell Antigen (PSCA) Diabody Enables Targeted Resection of Mouse Prostate Cancer Xenografts in Real Time.Protease specificity determination by using cellular libraries of peptide substrates (CLiPS).BioShuttle-mediated plasmid transfer.Determining glioma response to radiation therapy using recombinant peptides.Near-infrared fluorescence imaging of a solitary fibrous tumor of the pancreas using methylene blueProligands with protease-regulated binding activity identified from cell-displayed prodomain librariesC-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration.Oligocarbonate molecular transporters: oligomerization-based syntheses and cell-penetrating studies.
P2860
Q21143754-A8F9CF8A-E819-4803-9DD8-F9F8911460BDQ24675613-CE7C5436-75A2-4402-BDD1-462614708705Q26776370-B3842F76-A2C2-414E-8AE3-F380C822E034Q26828423-B6ECA24F-D1E1-452B-8DF6-0D4C70685935Q26829059-57ED6B12-10AE-4B95-8200-C30BC2142B5BQ26830028-E8D74437-DA49-4641-A528-3BD4C6C646A5Q26830905-C07F7985-CDD7-4283-ABE2-9684295CA01CQ26992127-2FCC00D2-C311-483D-B1C5-A198D8090AABQ27315827-8C80AB03-A1F1-4AF2-8ED8-6E02C56C1063Q27320124-B4A61278-5843-4904-A0F2-7FD5496445B0Q27342508-C3AB7402-6D28-484B-97C2-60B0F6F80C4DQ27687291-1F8B5820-A372-43A5-ABAA-D13E6C41CC0CQ27727742-64A5513F-1C32-49AA-885D-D8B4FFC9AAA9Q28072620-05313791-5A3F-43B0-9BD8-81255916AF2BQ28079386-50C376E5-B7A9-4F84-8DCB-18D15D65F6D4Q28478106-27219E14-2BC1-4C54-AE26-20626CC37B75Q28484118-B870C7F7-F114-41B5-AA5F-70F82935354BQ28647354-E455F317-A60A-4965-A163-5CB5E8F8A2B8Q29619858-BD2B95F6-F62D-4DE5-853B-0DC17DC1A09BQ30275458-5E96E25E-38BA-4EA7-97A5-7256FF905D45Q30355600-65D3583C-25FE-490F-9AAA-E217F93D1E0DQ30362001-1FCF8255-4AAD-47D7-9868-DD840AA745CFQ30365736-B50C2E08-4EF5-4225-A5CE-1C6122D47447Q30437844-539017C1-8744-4C83-83E2-549B69955702Q30441719-9B52EFBE-0399-4A8A-82AE-0D540C4FC97FQ30472058-5E6A35CD-D7EA-42E4-8C70-2314A41A1B41Q30474483-0172C51A-9D7A-4C48-B7E5-A1A734F48002Q30475818-2602A9C9-99FE-46A6-90C6-FA87B96E6849Q30476541-3E8C4C28-1709-47CE-AD31-555D9C7FFC85Q30490185-3BDA4EB1-A4E0-45F9-BD12-B23DFBA8B614Q30551927-2FF02429-56F3-4E81-A34A-7AB119D0F2E7Q30665133-A044F601-EBB9-47CE-9550-4C47B0E3A9DAQ30728281-84AEE9B0-A582-4B70-B1FB-F949285F13B9Q33242138-49BC6D34-AD17-4CA6-9F4F-D1543811D104Q33306508-27C8354C-4973-46A8-8786-F29CE97246CAQ33382467-D2B33D4D-C754-4DB1-8BAA-BD7830A2FE9CQ33402874-0002A9F5-8B1E-45CD-8CFD-1EF06BEBD89CQ33490199-7D728591-B1C3-45E0-9D89-C7CA05E74238Q33508760-CFC531E1-7F12-4776-91BE-7C32568768B4Q33512970-CEEB6DAB-9D6F-4181-A0D2-16AD31556F74
P2860
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
@ast
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
@en
Tumor imaging by means of proteolytic activation of cell-penetrating peptides.
@nl
type
label
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
@ast
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
@en
Tumor imaging by means of proteolytic activation of cell-penetrating peptides.
@nl
prefLabel
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
@ast
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
@en
Tumor imaging by means of proteolytic activation of cell-penetrating peptides.
@nl
P2093
P2860
P356
P1476
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
@en
P2093
Emilia S Olson
Melinda Roy
Patricia A Jennings
Quyen T Nguyen
Roger Y Tsien
P2860
P304
17867-17872
P356
10.1073/PNAS.0408191101
P407
P577
2004-12-15T00:00:00Z